Tresivac Injection
Mumps, Rubella, Measles (Live Attenuated) Vaccine
Serum Institute Of India Ltd
| Pack size | |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 245.99 NPR |
Indications
Tresivac Injection is used for:
Active immunization against infection by measles, mumps and rubella
Adult Dose
IM or SC
Active immunisation against measles, mumps and rubella
19-49 years old: 0.5 mL SC; second dose may be administered 28 days apart
>50 years old: 0.5 mL SC; administer 1 dose only
2nd dose recommendations
Student in postsecondary eduction
Recent exposure
Occupational risk
Previously vaccinated with killed measles vaccine
Vaccinated with unknown type of measles vaccine during 1963-67
International travelers
Healthcare personnel should consider receiving 2 doses of MMR vaccine at the appropriate interval for measles and mumps or 1 dose of MMR vaccine for rubella
Immunization in Pregnancy
Pregnant women who do not have evidence of immunity should receive MMR vaccine upon completion or termination of pregnancy and before discharge from the health-care facility
Pregnancy should be avoided for 28 days following vaccine administration
Child Dose
IM or SC
Active immunisation against measles, mumps and rubella
Routine vaccination: First dose of 0.5 mL SC between age 12-15 months; administer second dose between 4-6 yr. But may be administered during any visit
provided that at least 4 weeks have elapsed since the first dose and that both doses are administered beginning at or after age 12 months.
Those who have not received the second dose previously should complete the schedule by the visit at age 11–12 years.
Ensure all school-aged children and adolescents received 2 doses (0.5 mL SC each)
Minimum time between 1st and 2nd dose is 4 wk
Renal Dose
Administration
Contra Indications
Current febrile respiratory illness or other febrile infection. Patients receiving immunosuppressive therapy; primary and acquired immunodeficiency states. Blood dyscrasias, cancers affecting the bone marrow or lymphatic systems. Pregnancy. Active untreated tuberculosis.
Precautions
Patients with history of cerebral injury or seizures. Patients with thrombocytopenia and those who develop thrombocytopenia after 1st dose. For patients with active tuberculosis, tuberculosis treatment should be started before using the vaccine. Vaccination may be deferred in patients with moderate or severe acute illness. Pregnancy should be avoided for 28 days after vaccination. Lactation.
Lactation: Uot known if measles and mumps excreted in breast milk; rubella is excreted in milk; use caution
Pregnancy-Lactation
Interactions
Immune globulins may reduce the efficacy of vaccines. May reduce the diagnostic effect of tuberculin tests.
Potentially Fatal: Concurrent use with immunosuppressants may increase the adverse effects of vaccines; may also reduce the efficacy of vaccines.
Adverse Effects
Side effects of Mumps, Rubella, Measles (Live Attenuated) Vaccine :
Fever,Syncope,Ataxia,Pain at site,Headache,Rash,Lymphadenopathy,Myalgia,Stevens-Johnson syndrome,Thrombocytopenia,Optic neuritis,Encephalitis,Malaise,Irritability,Guillain-Barre synd,Subacute sclerosing panencephalitis (rare),Seizures,Parotitis,Bronchospasm,Leukocytosis,Conjunctivitis,Otitis media,Nerve deafness
Mechanism of Action
Live, attenuated viruses stimulate active immunity to disease caused by measles, rubella, and mumps viruses.
Note
Tresivac Injection manufactured by Serum Institute Of India Ltd. Its generic name is Mumps, Rubella, Measles (Live Attenuated) Vaccine. Tresivac is availble in Nepal.
Farmaco Nepal drug index information on Tresivac Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.